hydration effects glp-1 receptor agonists 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 medications have become a
Pay in 4 interest-free payments of $7.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
![hydration effects glp-1 receptor agonists 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 medications have become a](https://cdn.shopify.com/s/files/1/0689/4872/1903/files/jci151800.ga_1000x.jpg?v=1754930040)
![hydration effects glp-1 receptor agonists 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of GLP-1 medications have become a](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40265-025-02263-0/MediaObjects/40265_2025_2263_Fig1_HTML.png)
























